Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) Cash from Financing Activities (2016 - 2025)

Arrowhead Pharmaceuticals' Cash from Financing Activities history spans 16 years, with the latest figure at -$14.8 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities fell 171.48% year-over-year to -$14.8 million; the TTM value through Dec 2025 reached $38.6 million, down 95.66%, while the annual FY2025 figure was $74.0 million, 91.5% down from the prior year.
  • Cash from Financing Activities reached -$14.8 million in Q4 2025 per ARWR's latest filing, down from $3.7 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $430.8 million in Q1 2024 to a low of -$42.7 million in Q2 2025.
  • Average Cash from Financing Activities over 5 years is $62.7 million, with a median of $2.3 million recorded in 2021.
  • Peak YoY movement for Cash from Financing Activities: surged 82741.73% in 2024, then plummeted 184.7% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at $1.9 million in 2021, then surged by 13193.16% to $250.6 million in 2022, then plummeted by 99.89% to $267000.0 in 2023, then soared by 7628.09% to $20.6 million in 2024, then plummeted by 171.48% to -$14.8 million in 2025.
  • Per Business Quant, the three most recent readings for ARWR's Cash from Financing Activities are -$14.8 million (Q4 2025), $3.7 million (Q3 2025), and -$42.7 million (Q2 2025).